About McAlister Institute for Treatment
Services
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable)
Treatment Approaches
Anger management; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State department of health
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid
Special Programs/Groups Offered
Adult women; Pregnant/postpartum women
Assessment/Pre-treatment
Comprehensive substance use assessment; Screening for substance use
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; TB screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Medical Services
Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female
Language Services
Sign language services for the deaf and hard of hearing; Spanish
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Child care for clients' children; Social skills development; Transportation assistance
Type of Care
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient day treatment or partial hospitalization; Intensive outpatient treatment; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity; No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere; This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity; No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®); Buprenorphine with naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable)
Treatment Approaches
Anger management; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Trauma-related counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State department of health
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; Medicare; Medicaid
Special Programs/Groups Offered
Adult women; Pregnant/postpartum women
Assessment/Pre-treatment
Comprehensive substance use assessment; Screening for substance use
Testing
Breathalyzer or blood alcohol testing; Drug and alcohol oral fluid testing; Drug or alcohol urine screening; TB screening
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Mentoring/peer support; Employment counseling or training
Education and Counseling Services
HIV or AIDS education, counseling, or support; Hepatitis education, counseling, or support; Health education services other than HIV/AIDS or hepatitis; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Individual counseling; Group counseling
Medical Services
Hepatitis A (HAV) vaccination; Hepatitis B (HBV) vaccination
Facility Smoking Policy
Smoking permitted in designated area
Age Groups Accepted
Children/Adolescents
Gender Accepted
Female
Language Services
Sign language services for the deaf and hard of hearing; Spanish
Facility Vaping Policy
Vaping permitted in designated area
Ancillary Services
Case management service; Child care for clients' children; Social skills development; Transportation assistance
